Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection

NCT04337918 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

143

Enrollment

INDUSTRY

Sponsor class

Conditions

Corona Virus Infection

Interventions

DRUG: NORS (Nitric Oxide Releasing Solution)
DRUG: NORS (Nitric Oxide Releasing Solution)

Sponsor

Sanotize Research and Development corp.

Collaborators

[object Object]
[object Object]